Fact CheckerSign in

NCT06145737Active, not recruiting

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)

Source: ClinicalTrials.gov · Last updated 21 Nov 2025

Brief summary (registry, in English)

The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with multiple sclerosis (MS). The main questions it aims to answer are: 1. Can the current HOBSCOTCH program be adapted for people with MS? 2. Will people with MS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program? Participants will be asked to: * attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-MS sessions with a one-on-one certified HOBSCOTCH-MS coach * complete a brief clinical questionnaire about their diagnosis of MS * complete four questionnaires before and after the HOBSCOTCH-MS sessions about their quality of life and about memory and thinking processes * keep a short daily diary about their MS symptoms and use of the self-management strategies taught in the HOBSCOTCH-MS program * complete a brief Satisfaction Survey after the entire HOBSCOTCH-MS program

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
11 (actual)
First submitted
17 Nov 2023
Start date
2 Jan 2024
Primary completion date
1 Nov 2025
Lead sponsor
Dartmouth-Hitchcock Medical Center
NCT number
NCT06145737

What you commit to

  • Study type: Interventional
  • Participants enrolled: 11
  • From 2 Jan 2024 to the primary completion date, 1 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Significant visual impairment precluding reading or writing
  • Acute psychiatric illness
  • History of progressive neurodegenerative disease (dementia)

Other

  • Cognitive dysfunction that precludes participation in giving informed consent
  • No reliable telephone or internet access

Who the study is looking for

  • Age 20 - 65 years
  • Literate, English-speaking with grade 12 or equivalent in education
  • Self-reported diagnosis of MS
  • Self-reported cognitive/memory difficulties
  • Telephone and internet access

Age in the registry: 20 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dartmouth Hitchcock
Coordinator of this site? Confirm its status
LebanonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.